Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 164

1.

Phylodynamic analysis of HIV-1 subtypes B, C and CRF 02_AG in Senegal.

Nascimento FF, Baral S, Geidelberg L, Mukandavire C, Schwartz SR, Turpin G, Turpin N, Diouf D, Diouf NL, Coly K, Kane CT, Ndour C, Vickerman P, Boily MC, Volz EM.

Epidemics. 2019 Nov 14:100376. doi: 10.1016/j.epidem.2019.100376. [Epub ahead of print]

2.

National HIV testing and diagnosis coverage in sub-Saharan Africa: a new modeling tool for estimating the 'first 90' from program and survey data.

Maheu-Giroux M, Marsh K, Doyle CM, Godin A, Lanièce Delaunay C, Johnson LF, Jahn A, Abo K, Mbofana F, Boily MC, Buckeridge DL, Hankins CA, Eaton JW.

AIDS. 2019 Dec 15;33 Suppl 3:S255-S269. doi: 10.1097/QAD.0000000000002386.

PMID:
31764066
3.

Global and regional estimates of the contribution of herpes simplex virus type 2 infection to HIV incidence: a population attributable fraction analysis using published epidemiological data.

Looker KJ, Welton NJ, Sabin KM, Dalal S, Vickerman P, Turner KME, Boily MC, Gottlieb SL.

Lancet Infect Dis. 2019 Nov 18. pii: S1473-3099(19)30470-0. doi: 10.1016/S1473-3099(19)30470-0. [Epub ahead of print]

4.

HIV testing and engagement with the HIV treatment cascade among men who have sex with men in Africa: a systematic review and meta-analysis.

Stannah J, Dale E, Elmes J, Staunton R, Beyrer C, Mitchell KM, Boily MC.

Lancet HIV. 2019 Nov;6(11):e769-e787. doi: 10.1016/S2352-3018(19)30239-5. Epub 2019 Oct 7.

PMID:
31601542
5.

Increases in HIV Incidence Following Receptive Anal Intercourse Among Women: A Systematic Review and Meta-analysis.

Stannah J, Silhol R, Elmes J, Owen B, Shacklett BL, Anton P, McGowan I, van der Straten A, Dimitrov D, Baggaley RF, Boily MC.

AIDS Behav. 2019 Sep 4. doi: 10.1007/s10461-019-02651-0. [Epub ahead of print]

6.

Predicted effectiveness of daily and non-daily PrEP for MSM based on sex and pill-taking patterns from HPTN 067/ADAPT.

Dimitrov D, Moore JR, Wood D, Mitchell KM, Li M, Hughes JP, Donnell DJ, Mannheimer S, Holtz TH, Grant RM, Boily MC.

Clin Infect Dis. 2019 Aug 22. pii: ciz799. doi: 10.1093/cid/ciz799. [Epub ahead of print]

PMID:
31437276
7.

Early antiretroviral therapy and daily pre-exposure prophylaxis for HIV prevention among female sex workers in Cotonou, Benin: a prospective observational demonstration study.

Mboup A, Béhanzin L, Guédou FA, Geraldo N, Goma-Matsétsé E, Giguère K, Aza-Gnandji M, Kessou L, Diallo M, Kêkê RK, Bachabi M, Dramane K, Geidelberg L, Cianci F, Lafrance C, Affolabi D, Diabaté S, Gagnon MP, Zannou DM, Gangbo F, Boily MC, Vickerman P, Alary M.

J Int AIDS Soc. 2018 Nov;21(11):e25208. doi: 10.1002/jia2.25208.

8.

What Proportion of Female Sex Workers Practise anal Intercourse and How Frequently? A Systematic Review and Meta-analysis.

Owen BN, Baggaley RF, Elmes J, Harvey A, Shubber Z, Butler AR, Silhol R, Anton P, Shacklett B, van der Straten A, Boily MC.

AIDS Behav. 2019 Apr 5. doi: 10.1007/s10461-019-02477-w. [Epub ahead of print] Review.

9.

Improvements in the HIV care continuum needed to meaningfully reduce HIV incidence among men who have sex with men in Baltimore, US: a modelling study for HPTN 078.

Mitchell KM, Hoots B, Dimitrov D, German D, Flynn C, Farley JE, Gelman M, Hughes JP, Donnell D, Adeyeye A, Remien RH, Beyrer C, Paz-Bailey G, Boily MC.

J Int AIDS Soc. 2019 Mar;22(3):e25246. doi: 10.1002/jia2.25246.

10.

Assessing the utility of the tipping point ratio to monitor HIV treatment programmes in the era of universal access to ART.

de Montigny S, Boily MC, Mâsse BR, Mitchell KM, Dimitrov DT.

Infect Dis Model. 2018 Mar 14;3:85-96. doi: 10.1016/j.idm.2018.03.005. eCollection 2018.

11.

Cost-Effectiveness of Accelerated HIV Response Scenarios in Côte d'Ivoire.

Maheu-Giroux M, Diabaté S, Boily MC, Jean-Paul N, Vesga JF, Baral S, Abo K, Wognin V, Diouf D, Alary M.

J Acquir Immune Defic Syndr. 2019 Apr 15;80(5):503-512. doi: 10.1097/QAI.0000000000001956.

12.

Does per-act HIV-1 transmission risk through anal sex vary by gender? An updated systematic review and meta-analysis.

Baggaley RF, Owen BN, Silhol R, Elmes J, Anton P, McGowan I, van der Straten A, Shacklett B, Dang Q, Swann EM, Bolton DL, Boily MC.

Am J Reprod Immunol. 2018 Nov;80(5):e13039. doi: 10.1111/aji.13039. Epub 2018 Sep 2.

13.

The global response and unmet actions for HIV and sex workers.

Shannon K, Crago AL, Baral SD, Bekker LG, Kerrigan D, Decker MR, Poteat T, Wirtz AL, Weir B, Boily MC, Butler J, Strathdee SA, Beyrer C.

Lancet. 2018 Aug 25;392(10148):698-710. doi: 10.1016/S0140-6736(18)31439-9. Epub 2018 Jul 20. Review.

14.

Estimating the contribution of key populations towards the spread of HIV in Dakar, Senegal.

Mukandavire C, Walker J, Schwartz S, Boily MC, Danon L, Lyons C, Diouf D, Liestman B, Diouf NL, Drame F, Coly K, Muhire RSM, Thiam S, Diallo PAN, Kane CT, Ndour C, Volz E, Mishra S, Baral S, Vickerman P.

J Int AIDS Soc. 2018 Jul;21 Suppl 5:e25126. doi: 10.1002/jia2.25126.

16.

Review of mathematical models of HSV-2 vaccination: Implications for vaccine development.

Spicknall IH, Looker KJ, Gottlieb SL, Chesson HW, Schiffer JT, Elmes J, Boily MC.

Vaccine. 2019 Nov 28;37(50):7396-7407. doi: 10.1016/j.vaccine.2018.02.067. Epub 2018 Apr 4.

17.

Influence of model assumptions about HIV disease progression after initiating or stopping treatment on estimates of infections and deaths averted by scaling up antiretroviral therapy.

Sucharitakul K, Boily MC, Dimitrov D, Mitchell KM.

PLoS One. 2018 Mar 19;13(3):e0194220. doi: 10.1371/journal.pone.0194220. eCollection 2018.

18.

In what circumstances could nondaily preexposure prophylaxis for HIV substantially reduce program costs?

Mitchell KM, Dimitrov D, Hughes JP, Xia F, Donnell D, Amico KR, Bokoch K, Chitwarakorn A, Bekker LG, Holtz TH, Mannheimer S, Grant RM, Boily MC.

AIDS. 2018 Mar 27;32(6):809-818. doi: 10.1097/QAD.0000000000001766.

19.

Differences in risk behaviours and HIV status between primary amphetamines and opioid injectors in Estonia and Russia.

Tavitian-Exley I, Maheu-Giroux M, Platt L, Heimer R, Uusküla A, Levina O, Vickerman P, Boily MC.

Int J Drug Policy. 2018 Mar;53:96-105. doi: 10.1016/j.drugpo.2017.11.010. Epub 2018 Jan 5.

20.

Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models.

Brisson M, Bénard É, Drolet M, Bogaards JA, Baussano I, Vänskä S, Jit M, Boily MC, Smith MA, Berkhof J, Canfell K, Chesson HW, Burger EA, Choi YH, De Blasio BF, De Vlas SJ, Guzzetta G, Hontelez JAC, Horn J, Jepsen MR, Kim JJ, Lazzarato F, Matthijsse SM, Mikolajczyk R, Pavelyev A, Pillsbury M, Shafer LA, Tully SP, Turner HC, Usher C, Walsh C.

Lancet Public Health. 2016 Nov;1(1):e8-e17. doi: 10.1016/S2468-2667(16)30001-9. Epub 2016 Sep 27. Review.

21.

Recruitment of Female Sex Workers in HIV Prevention Trials: Can Efficacy Endpoints Be Reached More Efficiently?

Wood D, Lancaster KE, Boily MC, Powers KA, Donnell D, Cohen MS, Dimitrov DT.

J Acquir Immune Defic Syndr. 2018 Apr 1;77(4):350-357. doi: 10.1097/QAI.0000000000001603.

22.

Effect of HSV-2 infection on subsequent HIV acquisition: an updated systematic review and meta-analysis.

Looker KJ, Elmes JAR, Gottlieb SL, Schiffer JT, Vickerman P, Turner KME, Boily MC.

Lancet Infect Dis. 2017 Dec;17(12):1303-1316. doi: 10.1016/S1473-3099(17)30405-X. Epub 2017 Aug 23. Review.

23.

Polydrug Use and Heterogeneity in HIV Risk Among People Who Inject Drugs in Estonia and Russia: A Latent Class Analysis.

Tavitian-Exley I, Boily MC, Heimer R, Uusküla A, Levina O, Maheu-Giroux M.

AIDS Behav. 2018 Apr;22(4):1329-1340. doi: 10.1007/s10461-017-1836-0.

24.

Modelling efforts needed to advance herpes simplex virus (HSV) vaccine development: Key findings from the World Health Organization Consultation on HSV Vaccine Impact Modelling.

Gottlieb SL, Giersing B, Boily MC, Chesson H, Looker KJ, Schiffer J, Spicknall I, Hutubessy R, Broutet N; WHO HSV Vaccine Impact Modelling Meeting Working Group.

Vaccine. 2019 Nov 28;37(50):7336-7345. doi: 10.1016/j.vaccine.2017.03.074. Epub 2017 Jun 21.

25.

Anal Intercourse Among Female Sex Workers in Côte d'Ivoire: Prevalence, Determinants, and Model-Based Estimates of the Population-Level Impact on HIV Transmission.

Maheu-Giroux M, Baral S, Vesga JF, Diouf D, Diabaté S, Alary M, Abo K, Boily MC.

Am J Epidemiol. 2018 Feb 1;187(2):287-297. doi: 10.1093/aje/kwx244.

26.

Population-level impact of an accelerated HIV response plan to reach the UNAIDS 90-90-90 target in Côte d'Ivoire: Insights from mathematical modeling.

Maheu-Giroux M, Vesga JF, Diabaté S, Alary M, Baral S, Diouf D, Abo K, Boily MC.

PLoS Med. 2017 Jun 15;14(6):e1002321. doi: 10.1371/journal.pmed.1002321. eCollection 2017 Jun.

27.

Changing Dynamics of HIV Transmission in Côte d'Ivoire: Modeling Who Acquired and Transmitted Infections and Estimating the Impact of Past HIV Interventions (1976-2015).

Maheu-Giroux M, Vesga JF, Diabaté S, Alary M, Baral S, Diouf D, Abo K, Boily MC.

J Acquir Immune Defic Syndr. 2017 Aug 15;75(5):517-527. doi: 10.1097/QAI.0000000000001434.

28.

How common and frequent is heterosexual anal intercourse among South Africans? A systematic review and meta-analysis.

Owen BN, Elmes J, Silhol R, Dang Q, McGowan I, Shacklett B, Swann EM, van der Straten A, Baggaley RF, Boily MC.

J Int AIDS Soc. 2017 Jan 12;19(1):21162. doi: 10.7448/IAS.20.1.21162.

29.

Determinants of time from HIV infection to linkage-to-care in rural KwaZulu-Natal, South Africa.

Maheu-Giroux M, Tanser F, Boily MC, Pillay D, Joseph SA, Bärnighausen T.

AIDS. 2017 Apr 24;31(7):1017-1024. doi: 10.1097/QAD.0000000000001435.

30.

Criminal law, sex work, HIV: need for multi-level research.

Boily MC, Shannon K.

Lancet HIV. 2017 Mar;4(3):e98-e99. doi: 10.1016/S2352-3018(16)30219-3. Epub 2017 Jan 25. No abstract available.

31.

What Level of Risk Compensation Would Offset the Preventive Effect of Early Antiretroviral Therapy? Simulations From the TEMPRANO Trial.

Jean K, Boily MC, Danel C, Moh R, Badjé A, Desgrées-du-Loû A, Eholié S, Lert F, Dray-Spira R, Anglaret X, Ouattara E.

Am J Epidemiol. 2016 Nov 15;184(10):755-760. doi: 10.1093/aje/kww127.

32.

Epidemiology of HPV Genotypes among HIV Positive Women in Kenya: A Systematic Review and Meta-Analysis.

Menon S, Wusiman A, Boily MC, Kariisa M, Mabeya H, Luchters S, Forland F, Rossi R, Callens S, Vanden Broeck D.

PLoS One. 2016 Oct 20;11(10):e0163965. doi: 10.1371/journal.pone.0163965. eCollection 2016. Review.

33.

Potential impact of pre-exposure prophylaxis for female sex workers and men who have sex with men in Bangalore, India: a mathematical modelling study.

Mitchell KM, Prudden HJ, Washington R, Isac S, Rajaram SP, Foss AM, Terris-Prestholt F, Boily MC, Vickerman P.

J Int AIDS Soc. 2016 Sep 7;19(1):20942. doi: 10.7448/IAS.19.1.20942. eCollection 2016.

34.

Data and methods to characterize the role of sex work and to inform sex work programs in generalized HIV epidemics: evidence to challenge assumptions.

Mishra S, Boily MC, Schwartz S, Beyrer C, Blanchard JF, Moses S, Castor D, Phaswana-Mafuya N, Vickerman P, Drame F, Alary M, Baral SD.

Ann Epidemiol. 2016 Aug;26(8):557-569. doi: 10.1016/j.annepidem.2016.06.004. Epub 2016 Jun 15. Review.

35.

How Much Do We Know about Drug Resistance Due to PrEP Use? Analysis of Experts' Opinion and Its Influence on the Projected Public Health Impact.

Dimitrov DT, Boily MC, Hallett TB, Albert J, Boucher C, Mellors JW, Pillay D, van de Vijver DA.

PLoS One. 2016 Jul 8;11(7):e0158620. doi: 10.1371/journal.pone.0158620. eCollection 2016.

36.

A Bayesian approach to estimate changes in condom use from limited human immunodeficiency virus prevalence data.

Dureau J, Kalogeropoulos K, Vickerman P, Pickles M, Boily MC.

J R Stat Soc Ser C Appl Stat. 2016 Feb;65(2):237-257. Epub 2015 Aug 10.

37.

Assortative mixing as a source of bias in epidemiological studies of sexually transmitted infections: the case of smoking and human papillomavirus.

Lemieux-Mellouki P, Drolet M, Brisson J, Franco EL, Boily MC, Baussano I, Brisson M.

Epidemiol Infect. 2016 May;144(7):1490-9. doi: 10.1017/S0950268815002915. Epub 2015 Nov 20.

38.

Health and Economic Impact of Switching from a 4-Valent to a 9-Valent HPV Vaccination Program in the United States.

Brisson M, Laprise JF, Chesson HW, Drolet M, Malagón T, Boily MC, Markowitz LE.

J Natl Cancer Inst. 2015 Oct 4;108(1). pii: djv282. doi: 10.1093/jnci/djv282. Print 2016 Jan.

39.

Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis.

Drolet M, Bénard É, Boily MC, Ali H, Baandrup L, Bauer H, Beddows S, Brisson J, Brotherton JM, Cummings T, Donovan B, Fairley CK, Flagg EW, Johnson AM, Kahn JA, Kavanagh K, Kjaer SK, Kliewer EV, Lemieux-Mellouki P, Markowitz L, Mboup A, Mesher D, Niccolai L, Oliphant J, Pollock KG, Soldan K, Sonnenberg P, Tabrizi SN, Tanton C, Brisson M.

Lancet Infect Dis. 2015 May;15(5):565-80. doi: 10.1016/S1473-3099(14)71073-4. Epub 2015 Mar 3. Review.

40.

What really is a concentrated HIV epidemic and what does it mean for West and Central Africa? Insights from mathematical modeling.

Boily MC, Pickles M, Alary M, Baral S, Blanchard J, Moses S, Vickerman P, Mishra S.

J Acquir Immune Defic Syndr. 2015 Mar 1;68 Suppl 2:S74-82. doi: 10.1097/QAI.0000000000000437.

PMID:
25723994
41.

Prevalence and Frequency of Heterosexual Anal Intercourse Among Young People: A Systematic Review and Meta-analysis.

Owen BN, Brock PM, Butler AR, Pickles M, Brisson M, Baggaley RF, Boily MC.

AIDS Behav. 2015 Jul;19(7):1338-60. doi: 10.1007/s10461-015-0997-y. Review.

42.

Influence of different drugs on HIV risk in people who inject: systematic review and meta-analysis.

Tavitian-Exley I, Vickerman P, Bastos FI, Boily MC.

Addiction. 2015 Apr;110(4):572-84. doi: 10.1111/add.12846. Review.

PMID:
25582153
43.

Relationship between exposure to the Avahan intervention and levels of reported condom use among men who have sex with men in southern India.

Mitchell KM, Foss AM, Ramesh BM, Washington R, Isac S, Prudden HJ, Deering KN, Blanchard JF, Moses S, Lowndes CM, Boily MC, Alary M, Vickerman P.

BMC Public Health. 2014 Dec 4;14:1245. doi: 10.1186/1471-2458-14-1245.

44.

Changing inequalities in cervical cancer: modeling the impact of vaccine uptake, vaccine herd effects, and cervical cancer screening in the post-vaccination era.

Malagón T, Drolet M, Boily MC, Laprise JF, Brisson M.

Cancer Epidemiol Biomarkers Prev. 2015 Jan;24(1):276-85. doi: 10.1158/1055-9965.EPI-14-1052. Epub 2014 Nov 7.

45.

Community mobilisation and empowerment interventions as part of HIV prevention for female sex workers in Southern India: a cost-effectiveness analysis.

Vassall A, Chandrashekar S, Pickles M, Beattie TS, Shetty G, Bhattacharjee P, Boily MC, Vickerman P, Bradley J, Alary M, Moses S; CHARME India Group, Watts C.

PLoS One. 2014 Oct 21;9(10):e110562. doi: 10.1371/journal.pone.0110562. eCollection 2014.

46.

Cost-effectiveness of HIV prevention for high-risk groups at scale: an economic evaluation of the Avahan programme in south India.

Vassall A, Pickles M, Chandrashekar S, Boily MC, Shetty G, Guinness L, Lowndes CM, Bradley J, Moses S, Alary M; Charme India Group, Vickerman P.

Lancet Glob Health. 2014 Sep;2(9):e531-e540. doi: 10.1016/S2214-109X(14)70277-3. Epub 2014 Aug 27.

47.

Optimal allocation of resources in female sex worker targeted HIV prevention interventions: model insights from Avahan in South India.

Panovska-Griffiths J, Vassall A, Prudden HJ, Lépine A, Boily MC, Chandrashekar S, Mitchell KM, Beattie TS, Alary M, Martin NK, Vickerman P.

PLoS One. 2014 Oct 1;9(10):e107066. doi: 10.1371/journal.pone.0107066. eCollection 2014.

48.

Antiretroviral therapy uptake, attrition, adherence and outcomes among HIV-infected female sex workers: a systematic review and meta-analysis.

Mountain E, Mishra S, Vickerman P, Pickles M, Gilks C, Boily MC.

PLoS One. 2014 Sep 29;9(9):e105645. doi: 10.1371/journal.pone.0105645. eCollection 2014. Review.

49.

The HIV care cascade and antiretroviral therapy in female sex workers: implications for HIV prevention.

Mountain E, Pickles M, Mishra S, Vickerman P, Alary M, Boily MC.

Expert Rev Anti Infect Ther. 2014 Oct;12(10):1203-19. doi: 10.1586/14787210.2014.948422. Epub 2014 Aug 30. Review.

PMID:
25174997
50.

Comparing the cost-effectiveness of two- and three-dose schedules of human papillomavirus vaccination: a transmission-dynamic modelling study.

Laprise JF, Drolet M, Boily MC, Jit M, Sauvageau C, Franco EL, Lemieux-Mellouki P, Malagón T, Brisson M.

Vaccine. 2014 Oct 7;32(44):5845-53. doi: 10.1016/j.vaccine.2014.07.099. Epub 2014 Aug 12.

Supplemental Content

Loading ...
Support Center